GlobalRPH - Cancer/Oncology News

Medical News

< back to feeds
Cancer/Oncology News
Secretary Sebelius Statement On New Breast Cancer Recommendations HHS Secretary Kathleen Sebelius issued the following statement today on new breast cancer screening recommendations from the U.S. Preventive Services Task Force: "There is no question that the U.S. Preventive Services Task Force Recommendations have caused a great deal of confusion and worry among women and their families across this country. I want to address that confusion head on. The U.S. ...more	20 Nov 2009
Stopping Tissue Stiffening Is Key To Preventing Aggressive Cancers Scientists have identified an enzyme that is crucial for turning abnormal but non-malignant breast tissue into tumours, according to a study published today in Cell online. Blocking the enzyme lysyl oxidase (LOX) reduced the chance a tumour would form, and also meant tumours that did develop were smaller and less aggressive. ...more	20 Nov 2009
Is Type 2 Diabetes Mellitus A Risk Factor For Gallbladder, Biliary And Pancreatic Cancer? There are minimal data assessing the relationship between diabetes and gallbladder, biliary and pancreatic cancer. Recent small studies have suggested an elevated risk of pancreatic cancer only in patients with diabetes mellitus (DM). A research article published on November 14, 2009 in the World Journal of Gastroenterology addresses this question. The research team, lead by Dr. ...more	20 Nov 2009
Multidisciplinary Meeting On Urological Cancers Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next level. ...more	20 Nov 2009
NICE Appraisal Of Sorafenib For Advanced Hepatocellular Carcinoma The National Institute for Health and Clinical Excellence (NICE) is currently appraising the use of sorafenib for advanced hepatocellular carcinoma (HCC) in patients for whom surgery or therapies in the region the cancer arose have failed or are not suitable. In its latest draft guidance, published yesterday (19 November 2009), NICE does not recommend sorafenib. ...more	20 Nov 2009
'Chemofog' Takes Toll On Cancer Patients, Australia A condition that affects the memory and concentration of cancer patients undergoing chemotherapy is sustained in a subgroup of patients, compromising their ability to function and long-term quality of life, according to research presented on wednesday at a major cancer conference. ...more	20 Nov 2009
Treatment With Folic Acid, Vitamin B12 Associated With Increased Risk Of Cancer, Death Patients with heart disease in Norway, a country with no fortification of foods with folic acid, had an associated increased risk of cancer and death from any cause if they had received treatment with folic acid and vitamin B12, according to a study in the November 18 issue of JAMA. ...more	20 Nov 2009
Alnylam Presents New Pre-clinical Data On ALN-VSP, An RNAi Therapeutic For The Treatment Of Liver Cancer Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced new pre-clinical data from its ALN-VSP program presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International conference being held November 15 - 19, 2009 in Boston, Mass. ALN-VSP is an RNAi therapeutic currently in a Phase I clinical trial for the treatment of liver cancers, including hepatocellular carcinoma (HCC) and other solid tumors with liver involvement. ...more	20 Nov 2009
New Cancer Research Tool: Roche's CIM-Plate 16 Enables Real-Time Analysis Of Cell Migration On The XCELLigence System Roche Applied Science announces the availability of the new CIM-Plate 16 for their xCELLigence System for cell analysis, for use in cancer research. The 16-well culture plate features electronic sensors for the direct study of cell migration and invasion on the xCELLigence RTCA DP Instrument. ...more	20 Nov 2009
'Fly Paper' To Capture Circulating Cancer Cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. These cells, known as circulating tumor cells, or CTCs, can provide critical information for examining and diagnosing cancer metastasis, determining patient prognosis, and monitoring the effectiveness of therapies. ...more	20 Nov 2009
Cancers' Sweet Tooth May Be Weakness The pedal-to-the-metal signals driving the growth of several types of cancer cells lead to a common switch governing the use of glucose, researchers at Winship Cancer Institute of Emory University have discovered. Scientists who study cancer have known for decades that cancer cells tend to consume more glucose, or blood sugar, than healthy cells. ...more	20 Nov 2009
Susan G. Komen For The Cure(R) Recommends No Impediments To Breast Cancer Screening Susan G. Komen for the Cure®, the world's leading breast cancer advocacy organization, has carefully reviewed the data and new recommendations from the U.S. Preventive Services Task Force (USPSTF) concerning mammography screening. Komen for the Cure issued the following statement today from Eric P. Winer, M.D., chief scientific advisor and chair of Komen's Scientific Advisory Board. "Susan G. ...more	19 Nov 2009
MethylGene Reports Favorable Phase I Data For MGCD265 In Solid Tumors At The AACR-NCI-EORTC International Conference MethylGene Inc. (TSX:MYG) reported preliminary Phase I data for MGCD265 in a poster session at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference in Boston. MGCD265 is an oral, small molecule multi-targeted kinase inhibitor for cancer that targets the Met, VEGF, Ron and Tie-2 receptor tyrosine kinases thereby inhibiting multiple pathways involved in tumor growth, metastasis and angiogenesis. ...more	19 Nov 2009
Breast Cancer Campaign: New Breast Cancer Research Funding For Belfast Individualised radiotherapy treatment based on a person's genetic make up could soon become a reality, according to Breast Cancer Campaign. Professor Kevin Prise from Queen's University Belfast has been awarded a three year project grant by the charity to study how genes are involved in the effectiveness of radiotherapy treatment for breast cancer. The grant, worth more than Â£160,000, is part of Â£2 million awarded to 20 projects in the UK and Ireland. ...more	19 Nov 2009
CytRx To Initiate Phase 2 Clinical Trial With INNO-206 In Patients With Advanced Gastric Cancer CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company, today announced plans to initiate an open-label, multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a second-line treatment in patients with advanced gastric (stomach) cancer. CytRx President and CEO Steven A. Kriegsman said, "This planned clinical trial is a key step forward in our plans to build a commercial oncology franchise for CytRx. ...more	19 Nov 2009
People Looking For Information On Cancer Say Variety Is Key, UK PEOPLE looking for detailed information about cancer outside of hospitals need a range of different information sources, reveals a Cancer Research UK survey published in the November issue of Cancer Nursing Practice. Cancer Research UK's information nurse team used data from 300 telephone and email user satisfaction surveys* to examine why and how Cancer Research UK's Information Services*** were being used. ...more	19 Nov 2009
Common Pain Relief Medication May Encourage Cancer Growth Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. Two new studies advance that argument and demonstrate how shielding lung cancer cells from opiates reduces cell proliferation, invasion and migration in both cell-culture and mouse models. ...more	19 Nov 2009
Media Coverage Of New Mammography Guidelines Confusing To Some, Says Expert The public may have problems this week sorting through news articles about a government task force's opposition to routine mammograms for women under 50 and articles about breast cancer survivors touting the benefits of early mammograms. But to properly interpret the news, the public must learn to balance the research with the anecdotal evidence says University of Alabama at Birmingham (UAB) Associate Professor of English Cynthia Ryan, Ph.D. ...more	19 Nov 2009
NeoPharm Presents The Phase I Data For Patients With Metastatic Solid Tumors NeoPharm, Inc. (Other OTC: NEOL.PK) announced the results of a Phase I clinical trial of Liposome Encapsulated Docetaxel (LE-DT) an active component of Taxotere® at a joint International Conference of the American Association for Cancer Research (AACR), the National Cancer Institute (NCI) and the European Organization for Research and Treatment of Cancer (EORTC) being held in Boston, MA. ...more	19 Nov 2009
What Is Bone Cancer (Sarcoma)? What Causes Bone Cancer? Bone cancer is an uncommon cancer that begins in a bone. It can originate in any bone in the body, but the long bones that make up the arms and legs are most commonly affected. Several types of bone cancer exist. Some types of bone cancer occur primarily in children, while others affect mostly adults. Primary bone cancer is cancer that starts in the bone. ...more	19 Nov 2009
Pages of Results: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 [Next] [Last Page]
Cancer/Oncology News courtesy of Medical News Today	back to top

Medical News

Looking for a Job?

Career Center

Popular Tools

Disclaimer Contact Us Privacy Policy Website Search	We comply with the HONcode standard for health trustworthy information: Verify here. Copyright © 2007 GlobalRPh Inc.